Drug Free Solution, Inc. (OTCPK:DSOL) announced that it has entered into a equity purchase agreement for a private placement of equity line of credit for gross proceeds of $3,000,000 with new investor Premier Venture Partners, LLC on July 14, 2014. Pursuant to the agreement, the investor shall purchase the shares over a period of 36 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
2021 | Drug Free Solution, Inc. Announces Jessica Bass as CEO | CI |
2021 | Drug Free Solution, Inc. Announces Genie O'Malley as Chairwoman of the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 88.89K | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- DSOL Stock
- News Drug Free Solution, Inc.
- Drug Free Solution, Inc. announced that it expects to receive $3 million in funding from Premier Venture Partners, LLC